当前位置: 首页 >> 检索结果
6481. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
作者: Ole Fröbert.;Matthias Götberg.;David Erlinge.;Zubair Akhtar.;Evald H Christiansen.;Chandini R MacIntyre.;Keith G Oldroyd.;Zuzana Motovska.;Andrejs Erglis.;Rasmus Moer.;Ota Hlinomaz.;Lars Jakobsen.;Thomas Engstrøm.;Lisette O Jensen.;Christian O Fallesen.;Svend E Jensen.;Oskar Angerås.;Fredrik Calais.;Amra Kåregren.;Jörg Lauermann.;Arash Mokhtari.;Johan Nilsson.;Jonas Persson.;Per Stalby.;Abu K M M Islam.;Afzalur Rahman.;Fazila Malik.;Sohel Choudhury.;Timothy Collier.;Stuart J Pocock.;John Pernow.
来源: Circulation. 2021年144卷18期1476-1484页
Observational and small, randomized studies suggest that influenza vaccine may reduce future cardiovascular events in patients with cardiovascular disease.
6482. Pulsed-Field Ablation in Ventricular Myocardium Using a Focal Catheter: The Impact of Application Repetition on Lesion Dimensions.
作者: Hagai D Yavin.;Koji Higuchi.;Jakub Sroubek.;Arwa Younis.;Israel Zilberman.;Elad Anter.
来源: Circ Arrhythm Electrophysiol. 2021年14卷9期e010375页
[Figure: see text].
6483. Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis.
作者: Hua Wang.;Ke Chai.;Minghui Du.;Shengfeng Wang.;Jian-Ping Cai.;Yingying Li.;Ping Zeng.;Wanrong Zhu.;Siyan Zhan.;Jiefu Yang.
来源: Circ Heart Fail. 2021年14卷10期e008406页
Large-scale and population-based studies of heart failure (HF) incidence and prevalence are scarce in China. The study sought to estimate the prevalence, incidence, and cost of HF in China.
6484. Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation.
作者: Jacek Kwiecinski.;Evangelos Tzolos.;Timothy R G Cartlidge.;Alexander Fletcher.;Mhairi K Doris.;Rong Bing.;Jason M Tarkin.;Michael A Seidman.;Gaurav S Gulsin.;Nicholas L Cruden.;Anna K Barton.;Neal G Uren.;Michelle C Williams.;Edwin J R van Beek.;Jonathon Leipsic.;Damini Dey.;Raj R Makkar.;Piotr J Slomka.;James H F Rudd.;David E Newby.;Stephanie L Sellers.;Daniel S Berman.;Marc R Dweck.
来源: Circulation. 2021年144卷17期1396-1408页
Major uncertainties remain regarding disease activity within the retained native aortic valve, and regarding bioprosthetic valve durability, after transcatheter aortic valve implantation (TAVI). We aimed to assess native aortic valve disease activity and bioprosthetic valve durability in patients with TAVI in comparison with subjects with bioprosthetic surgical aortic valve replacement (SAVR).
6485. Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.
作者: Pieter C Smits.;Enrico Frigoli.;Jan Tijssen.;Peter Jüni.;Pascal Vranckx.;Yukio Ozaki.;Marie-Claude Morice.;Bernard Chevalier.;Yoshinobu Onuma.;Stephan Windecker.;Pim A L Tonino.;Marco Roffi.;Maciej Lesiak.;Felix Mahfoud.;Jozef Bartunek.;David Hildick-Smith.;Antonio Colombo.;Goran Stankovic.;Andrés Iñiguez.;Carl Schultz.;Ran Kornowski.;Paul J L Ong.;Mirvat Alasnag.;Alfredo E Rodriguez.;Aris Moschovitis.;Peep Laanmets.;Dik Heg.;Marco Valgimigli.; .
来源: Circulation. 2021年144卷15期1196-1211页
The optimal duration of antiplatelet therapy (APT) in patients at high bleeding risk with or without oral anticoagulation (OAC) after coronary stenting remains unclear.
6486. Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network.
作者: Anum Saeed.;Jianhui Zhu.;Floyd Thoma.;Oscar Marroquin.;Aryan Aiyer.;Anandita Agarwala.;Salim S Virani.;Martha Gulati.;Joon S Lee.;Steven Reis.;Samir Saba.;Christie Ballantyne.;Suresh Mulukutla.
来源: Circ Cardiovasc Qual Outcomes. 2021年14卷9期e007485页
Current American College of Cardiology/American Heart Association guidelines recommend using the 10-year atherosclerotic cardiovascular disease (ASCVD) risk to guide statin therapy for primary prevention. Real-world data on adherence and consequences of nonadherence to the guidelines in primary are limited. We investigated the guideline-directed statin intensity (GDSI) and associated outcomes in a large health care system, stratified by ASCVD risk.
6487. Effects of Walnut Consumption for 2 Years on Lipoprotein Subclasses Among Healthy Elders: Findings From the WAHA Randomized Controlled Trial.
作者: Sujatha Rajaram.;Montserrat Cofán.;Aleix Sala-Vila.;Ella Haddad.;Mercè Serra-Mir.;Edward Bitok.;Irene Roth.;Tania M Freitas-Simoes.;Amandeep Kaur.;Cinta Valls-Pedret.;Mónica Doménech.;Keiji Oda.;Dolores Corella.;Joan Sabaté.;Emilio Ros.
来源: Circulation. 2021年144卷13期1083-1085页 6488. Horizontal Aorta in Transcatheter Self-Expanding Valves: Insights From the HORSE International Multicentre Registry.
作者: Francesco Gallo.;Guglielmo Gallone.;Won-Keun Kim.;Jörg Reifart.;Verena Veulemans.;Tobias Zeus.;Stefan Toggweiler.;Ole De Backer.;Lars Søndergaard.;Antonio Mangieri.;Arif Khokhar.;Federico De Marco.;Damiano Regazzoli.;Bernhard Reimers.;Guillem Muntané-Carol.;Rodrigo Estévez-Loureiro.;Antonio Espino.;Marco Moscarelli.;Xavier Armario.;Darren Mylotte.;Riccardo Gorla.;Oliver Daniel Bhadra.;Lenard Conradi.;Luis Alfonso Marroquin Donday.;Luis Nombela-Franco.;Marco Barbanti.;Claudia Reddavid.;Enrico Criscione.;Salvatore Brugaletta.;Ander Regueiro.;Pedro Pérez-Fuentes.;Elisa Nicolini.;Tommaso Piva.;Giorgos Tzanis.;Josep Rodes-Cabau.;Antonio Colombo.;Francesco Giannini.
来源: Circ Cardiovasc Interv. 2021年14卷9期e010641页
[Figure: see text].
6489. Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL.
作者: Nicholas A Marston.;Robert P Giugliano.;Jeong-Gun Park.;Andrea Ruzza.;Peter S Sever.;Anthony C Keech.;Marc S Sabatine.
来源: Circulation. 2021年144卷21期1732-1734页 6490. Surgical Intervention of a Rare Case of Complex Coarctation of Descending Aorta.
作者: Hechen Shen.;Yan Yun.;Junjie Huang.;Zheng Zheng.;Diming Zhao.;Shanghao Chen.;Shijie Zhang.;Zezhong Wu.;Chengwei Zou.;Haizhou Zhang.;Xiaochun Ma.
来源: Circ Cardiovasc Imaging. 2021年14卷10期e013010页 6491. Health Impact and Cost-Effectiveness of Achieving the National Salt and Sugar Reduction Initiative Voluntary Sugar Reduction Targets in the United States: A Microsimulation Study.
作者: Siyi Shangguan.;Dariush Mozaffarian.;Stephen Sy.;Yujin Lee.;Junxiu Liu.;Parke E Wilde.;Andrea L Sharkey.;Erin A Dowling.;Matti Marklund.;Shafika Abrahams-Gessel.;Thomas A Gaziano.;Renata Micha.
来源: Circulation. 2021年144卷17期1362-1376页
High intake of added sugar is linked to weight gain and cardiometabolic risk. In 2018, the US National Salt and Sugar Reduction Initiative proposed government-supported voluntary national sugar reduction targets. This intervention's potential effects and cost-effectiveness are unclear.
6493. Late-Phase Delayed Coronary Obstruction Caused by Protruding Calcified Aortic Valve Leaflet After Balloon-Expandable Transcatheter Aortic Valve Replacement.
作者: Keisuke Yasumura.;Sunny Goel.;Parasuram Krishnamoorthy.;Samantha M Lee.;Samin K Sharma.;Gilbert H L Tang.;Annapoorna S Kini.
来源: Circ Cardiovasc Imaging. 2021年14卷9期e012854页 6494. Initial Experience With the PASCAL Ace Implant System for Treatment of Severe Tricuspid Regurgitation.
作者: Matthias Aurich.;Martin J Volz.;Derliz Mereles.;Nicolas A Geis.;Norbert Frey.;Mathias H Konstandin.;Philip W Raake.
来源: Circ Cardiovasc Interv. 2021年14卷9期e010770页
[Figure: see text].
6495. Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve: A Propensity-Matched Analysis From the United States.
作者: Tamim M Nazif.;Thomas J Cahill.;David Daniels.;James M McCabe.;Mark Reisman.;Tarun Chakravarty.;Raj Makkar.;Amar Krishnaswamy.;Samir Kapadia.;Bassem M Chehab.;John Wang.;Christian Spies.;Evelio Rodriguez.;Tsuyoshi Kaneko.;Rebecca T Hahn.;Martin B Leon.;Isaac George.
来源: Circ Cardiovasc Interv. 2021年14卷9期e010543页
[Figure: see text].
6496. Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA).
作者: Justin A Ezekowitz.;Yinggan Zheng.;Alain Cohen-Solal.;Vojtěch Melenovský.;Jorge Escobedo.;Javed Butler.;Adrian F Hernandez.;Carolyn S P Lam.;Christopher M O'Connor.;Burkert Pieske.;Piotr Ponikowski.;Adriaan A Voors.;Christopher deFilippi.;Cynthia M Westerhout.;Ciaran McMullan.;Lothar Roessig.;Paul W Armstrong.
来源: Circulation. 2021年144卷18期1489-1499页
In the VICTORIA trial (Vericiguat Global Study in Patients with Heart Failure with Reduced Ejection Fraction), anemia occurred more often in patients treated with vericiguat (7.6%) than with placebo (5.7%). We explored the association between vericiguat, randomization hemoglobin, development of anemia, and whether the benefit of vericiguat related to baseline hemoglobin.
6498. Characterizing Sex Differences in Physical Frailty Phenotypes in Heart Failure.
作者: Quin E Denfeld.;Beth A Habecker.;S Albert Camacho.;Mary Roberts Davis.;Nandita Gupta.;Shirin O Hiatt.;Mary E Medysky.;Jonathan Q Purnell.;Kerri Winters-Stone.;Christopher S Lee.
来源: Circ Heart Fail. 2021年14卷9期e008076页
Although women with heart failure (HF) are potentially more likely to be physically frail compared with men with HF, the underlying contributors to this sex difference are poorly understood. The purpose of this study was to characterize sex differences in physical frailty phenotypes in HF.
6500. Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings.
作者: Dana Viskin.;Yan Topilsky.;Galit Aviram.;Tomer Mann.;Sapir Sadon.;Yitzhac Hadad.;Nir Flint.;Haim Shmilovich.;Shmuel Banai.;Ofer Havakuk.
来源: Circ Cardiovasc Imaging. 2021年14卷9期e013236页 |